Efficacy of Mavacamten in Reducing Cardiac Obstruction in an Elderly Patient with Hypertrophic Cardiomyopathy: A Case Study

Nicolas Andre; Ariel Galor; Katie Testa; Jericho Sumalbag; Shaya Manouchehri; Uri Meir Ben-Zur

doi:10.12659/AJCR.946956

18 April 2025 : Case report Israel

Efficacy of Mavacamten in Reducing Cardiac Obstruction in an Elderly Patient with Hypertrophic Cardiomyopathy: A Case Study

Unusual or unexpected effect of treatment

Nicolas Andre

^1ABDEF, Ariel Galor^2ADEF, Katie Testa^3ABCE, Jericho Sumalbag^3ACDE, Shaya Manouchehri^3ABCDEF*, Uri Meir Ben-Zur^3ABCDEFG

DOI: 10.12659/AJCR.946956

Am J Case Rep 2025; 26:e946956

Authors information Article notes Copyright and License information

Introduction Case Report Discussion Conclusions References:

Related articles Order reprints Share article Share by email

View HTML version

Figure 5. Left ventricular outflow tract velocity at rest, measured in a 91-year-old patient with hypertrophic cardiomyopathy 2 months after increasing the daily Mavacamten dose to 10 mg.

Back to the Article

Efficacy of Mavacamten in Reducing Cardiac Obstruction in an Elderly Patient with Hypertrophic Cardiomyopathy: A Case Study

Your Privacy